Pacira Biosciences Inc
PCRX22.530USD
+0.340+1.53%
交易中 （美东）报价延迟15分钟
1.01B总市值
亏损市盈率 TTM
关于 Pacira Biosciences Inc 公司
Pacira BioSciences, Inc. 是 Pacira Pharmaceuticals, Inc. 的控股公司。该公司的非阿片类治疗药物包括 EXPAREL（布比卡因脂质体注射混悬液），这是一种用于术后疼痛管理的长效局部镇痛药；ZILRETTA（曲安奈德缓释注射混悬液），这是一种缓释关节内 (IA) 皮质类固醇注射剂，用于治疗 OA 膝关节疼痛；以及 Iovera，这是一种新型手持设备，可通过精确控制的低温剂量向目标神经提供即时、长效、无药物的疼痛控制。EXPAREL 用于多种骨科手术，包括关节重建、肩部、脊柱、四肢手术和髋部骨折。该公司正在开发干预措施来治疗涉及交感神经系统的衰弱性疾病，例如心脏电风暴、慢性疼痛。其临床开发项目包括 PCRX-201 和基于 pMVL 的临床项目。
Pacira Biosciences Inc简介
公司代码PCRX
公司名称Pacira Biosciences Inc
上市日期Feb 03, 2011
CEOMr. Frank D. Lee
员工数量790
证券类型Ordinary Share
年结日Feb 03
公司地址2000 Sierra Point Parkway
城市BRISBANE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94005
电话16502428052
网址https://www.pacira.com/
公司代码PCRX
上市日期Feb 03, 2011
CEOMr. Frank D. Lee
Pacira Biosciences Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mark A. Kronenfeld, M.D.
Dr. Mark A. Kronenfeld, M.D.
Independent Director
Independent Director
34.90K
+40.15%
Dr. Jonathan Slonin, M.D.
Dr. Jonathan Slonin, M.D.
Chief Medical Officer
Chief Medical Officer
34.37K
-0.91%
Mr. Daryl Gaugler
Mr. Daryl Gaugler
Executive Vice President - Commercial Operations
Executive Vice President - Commercial Operations
32.29K
-51.29%
Ms. Laura A. Brege
Ms. Laura A. Brege
Independent Chairman of the Board
Independent Chairman of the Board
23.71K
+35.11%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
9.04K
-20.66%
Ms. Lauren Riker
Ms. Lauren Riker
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
5.98K
-59.94%
Mr. Michael J. Yang
Mr. Michael J. Yang
Independent Director
Independent Director
--
--
Mr. Shawn M. Cross
Mr. Shawn M. Cross
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Marcelo Bigal, M.D., Ph.D.
Dr. Marcelo Bigal, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Susan Mesco
Ms. Susan Mesco
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Mark A. Kronenfeld, M.D.
Dr. Mark A. Kronenfeld, M.D.
Independent Director
Independent Director
34.90K
+40.15%
Dr. Jonathan Slonin, M.D.
Dr. Jonathan Slonin, M.D.
Chief Medical Officer
Chief Medical Officer
34.37K
-0.91%
Mr. Daryl Gaugler
Mr. Daryl Gaugler
Executive Vice President - Commercial Operations
Executive Vice President - Commercial Operations
32.29K
-51.29%
Ms. Laura A. Brege
Ms. Laura A. Brege
Independent Chairman of the Board
Independent Chairman of the Board
23.71K
+35.11%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
9.04K
-20.66%
Ms. Lauren Riker
Ms. Lauren Riker
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
5.98K
-59.94%
收入明细
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
业务USD
名称
营收
占比
EXPAREL
142.92M
0.00%
ZILRETTA
31.33M
0.00%
iovera
5.59M
0.00%
Bupivacaine liposome injectable suspension
508.00K
0.00%
暂无数据
业务
地区
业务USD
名称
营收
占比
EXPAREL
142.92M
0.00%
ZILRETTA
31.33M
0.00%
iovera
5.59M
0.00%
Bupivacaine liposome injectable suspension
508.00K
0.00%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.89%
The Vanguard Group, Inc.
11.92%
DOMA Perpetual Capital Management, LLC
6.01%
Renaissance Technologies LLC
5.33%
D. E. Shaw & Co., L.P.
5.01%
其他
56.84%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.89%
The Vanguard Group, Inc.
11.92%
DOMA Perpetual Capital Management, LLC
6.01%
Renaissance Technologies LLC
5.33%
D. E. Shaw & Co., L.P.
5.01%
其他
56.84%
股东类型
持股股东
占比
Investment Advisor
51.44%
Investment Advisor/Hedge Fund
29.98%
Hedge Fund
25.77%
Research Firm
5.21%
Pension Fund
2.17%
Individual Investor
1.51%
Bank and Trust
1.03%
Holding Company
0.30%
Sovereign Wealth Fund
0.04%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
594
52.02M
115.78%
-16.12M
2025Q2
613
53.27M
118.43%
-16.03M
2025Q1
638
53.73M
116.03%
-16.46M
2024Q4
638
52.13M
112.66%
-21.91M
2024Q3
638
53.62M
116.22%
-11.06M
2024Q2
624
54.29M
116.65%
-6.10M
2024Q1
627
51.47M
110.71%
-7.99M
2023Q4
621
50.55M
108.88%
-6.71M
2023Q3
612
49.73M
107.18%
-6.05M
2023Q2
605
49.27M
107.14%
-5.45M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
6.69M
14.89%
-72.97K
-1.08%
Jun 30, 2025
The Vanguard Group, Inc.
5.36M
11.92%
+165.93K
+3.20%
Jun 30, 2025
DOMA Perpetual Capital Management, LLC
2.70M
6.01%
+894.55K
+49.59%
Aug 05, 2025
Renaissance Technologies LLC
2.40M
5.33%
--
--
Jun 30, 2025
D. E. Shaw & Co., L.P.
2.25M
5.01%
-10.54K
-0.47%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.15M
4.79%
+102.21K
+4.99%
Jun 30, 2025
Balyasny Asset Management LP
2.13M
4.74%
+565.29K
+36.11%
Jun 30, 2025
State Street Investment Management (US)
1.95M
4.34%
-28.76K
-1.45%
Jun 30, 2025
American Century Investment Management, Inc.
1.18M
2.63%
+515.09K
+77.18%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.14M
2.54%
+5.66K
+0.50%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Invesco Pharmaceuticals ETF
2.69%
SPDR S&P Pharmaceuticals ETF
1.8%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
ETC 6 Meridian Small Cap Equity ETF
1.09%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.94%
Simplify Health Care ETF
0.92%
Invesco S&P SmallCap Health Care ETF
0.74%
VictoryShares Small Cap Free Cash Flow ETF
0.7%
Royce Quant Small-Cap Quality Value ETF
0.53%
Distillate Small/Mid Cash Flow ETF
0.48%
查看更多
Invesco Pharmaceuticals ETF
占比2.69%
SPDR S&P Pharmaceuticals ETF
占比1.8%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.35%
ETC 6 Meridian Small Cap Equity ETF
占比1.09%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比0.94%
Simplify Health Care ETF
占比0.92%
Invesco S&P SmallCap Health Care ETF
占比0.74%
VictoryShares Small Cap Free Cash Flow ETF
占比0.7%
Royce Quant Small-Cap Quality Value ETF
占比0.53%
Distillate Small/Mid Cash Flow ETF
占比0.48%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
